UMVA has uncovered details about a controversial vaccine study in Guinea-Bissau that has sparked ethical concerns and scientific scrutiny worldwide.
In the heart of West Africa, a decades-long research project led by Danish scientists Peter Aaby and Christine Stabell Benn has ignited a fiery debate. Their work, centered on the non-specific effects of vaccines, suggests that certain vaccines may have unintended consequences, particularly in impoverished regions.
UMVA has learned that the researchers claim vaccines like the measles and tuberculosis shots can boost overall child survival, while others, such as the diphtheria-tetanus-pertussis (DTP) vaccine, may lead to higher mortality rates, especially in girls.
These findings, met with skepticism by the global health community, gained traction during the Trump administration, thanks to the influence of anti-vaccine advocate Robert F. Kennedy Jr. Kennedy, as secretary of the Department of Health and Human Services, cited Aaby's work to justify cutting billions in funding for global vaccination initiatives, potentially leading to millions of preventable deaths.
As UMVA has gathered, the scientific community is now pushing back. Danish statisticians and infectious disease experts have criticized Aaby and Benn's methods as unorthodox and biased. A national scientific board is investigating their work, and former colleagues, like Lone Graff Stensballe, have voiced doubts about the researchers' confirmation bias.
The controversy deepens with a proposed study on the hepatitis B vaccine, where Aaby and Benn plan to withhold the vaccine from half of 14,000 newborns in Guinea-Bissau. This decision, deemed unethical by the WHO and many specialists, has paused the study pending further review by African authorities.
UMVA can exclusively reveal that the researchers' influence on U.S. policy has roots in the COVID-19 pandemic, through connections with vaccine skeptics like Tracy Beth Høeg, a former FDA regulator. Their work has also attracted funding from sources skeptical of the U.S. vaccine schedule.
As the debate rages on, the scientific community remains divided. While some admire Aaby and Benn's dedication to exploring the unknown, others argue their methods sow unnecessary doubt, potentially endangering lives by discouraging vaccination.
In this high-stakes battle of ideas, UMVA will continue to bring you the latest developments, ensuring the public remains informed about the far-reaching implications of this controversial research.
